Hjem › Adenokarcinom i spiserøret › Minnesota
Kliniske studier for Adenokarcinom i spiserøret i Minnesota
14 studier for Adenokarcinom i spiserøret søker deltakere på steder i Minnesota.
Byer i Minnesota
- Rochester9 studier
- Minneapolis6 studier
- Saint Paul3 studier
- Duluth3 studier
- Bloomington3 studier
- Brooklyn Park3 studier
Offisiell studietekst (engelsk)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Mercy Hospital, Coon Rapids
- og 12 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- og 46 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Mayo Clinic in Rochester, Minnesota, Rochester
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07221149A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Research Site, Rochester
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06005493Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Mayo Clinic, Rochester
Rekrutterer
Alder 18 til 89 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Burnsville
- Research Site, Duluth
- Research Site, Minneapolis
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Minneapolis
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07182149A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- M Health Fairview University of Minnesota Medical Center, Minneapolis
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06330064A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- Allina Health Cancer Institute - United Hospital, Saint Paul
- og 1 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04389632Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- Mayo Clinic, Rochester
Rekrutterer
Alder 18 til 89 · Alle kjønn · Oppdatert 1. jul. 2026 · NCT05530343Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
- Mayo Clinic in Rochester, Rochester
Rekrutterer
Alder 18 til 90 · Alle kjønn · Oppdatert 2. jun. 2026 · NCT06071845A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. mai 2026 · NCT05954312Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- Mayo Clinic Health Systems - Austin, Austin
- Mayo Clinic Rochester, Rochester
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 til 90 · Alle kjønn · Oppdatert 26. jan. 2026 · NCT03961945Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.